Indicaciones y resultados de retrasplante hepático: experiencia del hospital universitario La Fe (1.181 pacientes)

Despite the increased morbidity and mortality of LrT, it appears that this treatment alternative is still valid in those patients with an early loss of the liver graft. On the other hand, when the graft loss is delayed, it needs to be defined, what would be the minimum acceptable results to indicate LrT and which patients could benefit from this treatment.